SCHEMBL27745477

SCHEMBL27745477

NN(C(=O)O)c1cc(Cl)ccn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
ALDH1A1 P00352 1/20 0.45
KDM4C Q9H3R0 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.36
TSHR P16473 1/20 0.36
CASP1 P29466 1/20 0.36
KMO O15229 3/20 0.36
GABRP O00591 1/20 0.34
GABRD O14764 1/20 0.34
GABRA1 P14867 1/20 0.34
GABRB1 P18505 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
GABRA5 P31644 1/20 0.34
GABRA3 P34903 1/20 0.34
GABRA2 P47869 1/20 0.34
GABRB2 P47870 1/20 0.34
GABRA4 P48169 1/20 0.34
GABRE P78334 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27584824 0.76 GABRP (0.40) MAPTALDH1A1KDM4CGABRPGABRD
SCHEMBL18604297 0.76 MAPT (0.54) MAPTL3MBTL1ALDH1A1KDM4CTSHR
SCHEMBL1094625 0.75 L3MBTL1 (0.42) MAPTL3MBTL1ALDH1A1KDM4CSMN1; SMN2
SCHEMBL27768259 0.73 L3MBTL1 (0.42) MAPTL3MBTL1ALDH1A1SMN1; SMN2NPSR1
SCHEMBL19668416 0.72 TSHR (0.54) L3MBTL1ALDH1A1SMN1; SMN2TSHRNPSR1
SCHEMBL28161833 0.71 HCAR2 (0.35)
SCHEMBL2234423 0.70 MAPT (0.38) MAPTL3MBTL1ALDH1A1KDM4CTSHR
SCHEMBL6038491 0.69 L3MBTL1 (0.41) MAPTL3MBTL1ALDH1A1KDM4CSMN1; SMN2
SCHEMBL827405 0.69 ALDH1A1 (0.41) MAPTL3MBTL1ALDH1A1
SCHEMBL5104290 0.68 L3MBTL1 (0.42) MAPTL3MBTL1ALDH1A1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101472920-A Selective inhibitors of ROCK protein kinase and uses thereof VERTEX PHARMA (US) 2009-07-01 CN disclosed